C Patrick Reynolds

Biography

 Dr. Reynolds, the Cancer Center Director and Associate Dean for Research TTUHSC SOM, is an internationally-recognized expert in development of novel drugs to treat cancer. His laboratory and clinical research led to use of a drug derived from vitamin A (13-cis-retinoic acid) to treat the childhood cancer neuroblastoma, a therapy that is now part of the world-wide standard of care. He is active in laboratory drug development research and also in the design and conduct of phase I, II, and III oncology clinical trials in both pediatric and adult oncology. Dr. Reynolds holds active grant support in cancer research from the National Cancer Institute, Department of Defense, the Children's Oncology Group, and he sponsors Investigational New Drug applications (IND) with the Food & Drug Administration. He serves on national advisory panels for the National Cancer Institute, the Food & Drug Administration, the Children's Oncology Group, and the National Institute of Child Health and Development. He has published more than 100 scientific papers on cancer drug development.

Research Interest

 pediatric and adult oncology